| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877658 | The Annals of Thoracic Surgery | 2011 | 7 Pages |
Abstract
Intramyocardial injection of mesenchymal stem cells pretreated with TGF-α further protects cardiac function and reduces infarct size compared with injection of untreated cells. Pretreating donor cells with TGF-α may be useful for enhancing cell-based therapies for myocardial ischemia.
Keywords
MSCLVESDLVDPLVEFLVEDdTgf-αleft ventricleLeft ventricular developed pressuretransforming growth factor-αstandard error of the meanMesenchymal stem cellVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)left ventricular end-diastolic diameterleft ventricular end-systolic diameterLADSEMleft anterior descendingleft ventricular ejection fractionfractional shortening
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeremy L. MD, Aaron M. MD, Yue PhD, Brent R. MD, Jeffrey A. MD, Mariuxi C. MD, Daniel R. MD,